|
Pharmaceutical Technology Europe
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
Total result: 745 articles |
 Page 1 of 10 
|
PTE's new look website.
September 01, 2009
Tailor-made medicine drives M&As.
September 01, 2009
Where will the economic crisis leave pharma and biotech?
September 01, 2009
The combination drugs debate.
September 01, 2009
Clinical trials corruption.
September 01, 2009
Pfizer Vs. Nigeria.
September 01, 2009
Threat to chemical sector.
September 01, 2009
EMEA and FDA collaborate.
September 01, 2009
The changing face of outsourcing.
September 01, 2009
What to consider when expanding business into North America: increase ...
September 01, 2009
Belgium: will its enviable geographic position continue to ensure succ...
September 01, 2009
Europe needs generic medicines faster.
July 01, 2009
Pharma gone green.
July 01, 2009
Penny-wise, pound-foolish: pharma companies that sell redundant facili...
July 01, 2009
EU and US unite against rare diseases.
July 01, 2009
Human error costs industry billions: employee misunderstanding is the ...
July 01, 2009
Funding for API purification.
July 01, 2009
Are we moving towards global patenting?
July 01, 2009
The 'pepper pot' principle: ensuring the most effective drugs reach th...
July 01, 2009
The first batch is ready ...
July 01, 2009
Thinking of theranostics? Are manufacturers ready to deal with the eco...
July 01, 2009
Changes to EU DTC rules?
July 01, 2009
New directive halted.
July 01, 2009
Anti-counterfeiting project.
July 01, 2009
Pharma's Facebook: social media is one of the biggest success stories ...
July 01, 2009
Dynamic avalanching accurately assesses flowability and quality.
July 01, 2009
Automated Robotics.
July 01, 2009
Expression systems royalties battle: with all of the new expressions s...
July 01, 2009
Nanotechnology: the next silver bullet?
July 01, 2009
Transatlantic integration a necessity.
July 01, 2009
New expression systems create opportunities for innovators, CMOs and p...
June 01, 2009
Where have we reached with REACH?
June 01, 2009
Limits to CRO growth? A major CRO ventures further into proprietary dr...
June 01, 2009
The R&D hurdles for neglected diseases: modern medicines have dramatic...
June 01, 2009
Substandard APIs: we must tackle the problem together.
June 01, 2009
Why we need mass serialization--now! Gary Noon argues the case for mas...
June 01, 2009
Taking the modular approach for effective facility validation: when va...
June 01, 2009
Acceptable compromise?
June 01, 2009
A grim fate for 2009 pharma?
June 01, 2009
Patent pool and HIV initiative.
May 01, 2009
Rising clinical trials costs.
May 01, 2009
US patent ruling will hit EU pharma.
May 01, 2009
UK cell therapy industry faces market failure.
May 01, 2009
Know thy market: information and technology.
May 01, 2009
The FDA's new direction: with a new head of the FDA expected to be ann...
May 01, 2009
Orally disintegrating tablets: the path to improved patient compliance...
May 01, 2009
The rainbow nation--a spectrum of opportunities.
May 01, 2009
Elevating laboratory informatics to assist decision-making.
May 01, 2009
Tackling malaria.
May 01, 2009
Maintaining manufacturing.
May 01, 2009
Managing the market--distribution and logistics.
May 01, 2009
Outsourcing clinical trials: growth continues.
May 01, 2009
Bioanalytical laboratories: facing future challenges: Bioanalytical la...
May 01, 2009
Case study: creating a blueprint for pharmaceutical distribution.
May 01, 2009
When the going gets tough ... pharmaceutical technology Europe (PTE) t...
April 01, 2009
Upcoming technologies to facilitate more efficient biologics manufactu...
April 01, 2009
Particle size analysis: an expert on diffraction systems offers insigh...
April 01, 2009
Counterfeits: reducing the growing threat: steps companies can take to...
April 01, 2009
Achema 2009: Frankfurt readies itself for international congress ...
April 01, 2009
Drug discovery the cheap way.
April 01, 2009
Managing the risks of PAT: operational excellence awaits, but only if ...
April 01, 2009
Pharma's silver lining: despite the market downturn and financial melt...
April 01, 2009
Characterizing amorphous materials with gravimetric vapour sorption te...
April 01, 2009
Darwin's unique batch and product.
April 01, 2009
LIMS with web interface.
April 01, 2009
Misery for AstraZeneca.
March 01, 2009
Phase 0 offers advantages.
March 01, 2009
Ensuring raw material quality: this month's expert examines the most a...
March 01, 2009
Quantifying experience in powder processing: enshrined in the concept ...
March 01, 2009
Predictive modelling: putting ICH guidelines to work in process valida...
March 01, 2009
Modular clean room.
March 01, 2009
Facilitating technology transfer to your CMO: Michiel Ultee talks abou...
March 01, 2009
PAT: HPLC on the horizon? PAT guidance has been available from FDA for...
March 01, 2009
Unfavourable trial results go unpublished.
March 01, 2009
Abating counterfeit medicine fears.
March 01, 2009
|
1